Skip to content

Author

S. Harmon

We have 4 of 62 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Image-based Detection of Mismatch Repair Deficiency in Prostate Cancer Using Transfer Learning.

PURPOSE/BACKGROUND Tumors with microsatellite instability high/mismatch repair-deficient (MSI-H/dMMR) exhibit distinct biological features and are associated with Lynch syndrome. Current approaches for detecting MSI-H/dMMR status rely on immunohistochemistry or molecular assays. Recent advances in digital pathology hav...

L. J. Liu, R. Etzioni, Hao-Yue Zhang et al. · 0 citations
Open access Sep 2026

Impact of MRI Quality on the Accuracy of Targeted Prostate Biopsy: A Prospective PI-QUAL Analysis

Background and Objectives: Multiparametric MRI (mpMRI) has improved the detection of clinically significant prostate cancer (csPCa). However, the diagnostic utility of mpMRI is heavily dependent on image quality, which is often inconsistent across clinical settings. We investigated the association between mpMRI quality...

Donald C. Wunsch, O. Esengur, R. Makwana et al. · 0 citations
Open access Sep 2026

Defining a Safe Biopsy Deferral Strategy in Patients With Low-Risk or Equivocal MRI Findings Using Prostate-Specific Antigen-Based Metrics.

This prospective single-center study examined whether prostate-specific antigen (PSA)-based measures could identify a low-risk subgroup suitable for biopsy deferral in patients with Prostate Imaging-Reporting and Data System (PI-RADS) 1-3 lesions, and which clinical & imaging factors further refined risk stratification...

O. Esengur, S. Harmon, Emma J. Stevenson et al. · 0 citations
Open access Aug 2026

Deep learning-based histologic classifiers enable molecular subtyping of metastatic prostate cancer.

A deep learning model that leverages interpretable cellular features to improve feature extraction from H&E-stained tissue sections (NEURAL-PC) and represents an extensively validated diagnostic and prognostic model for advanced prostate cancer.

Zhi-Jun Chen, Erolcan Sayar, D. Guevara et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.